UC Riverside has partnered the Know Hub Chile partnership to help Chile conduct better research and tech transfer.

Cambridge spinout Crescendo Biologics has leveraged its transgenic protein discovery platform to license out an antibody to biopharmaceutical developer Zai Lab.

MCR Therapeutics will develop peptides to stimulate the production of melanin, a pigment which shields humans against ultraviolet rays and skin cancer.

ChromaCure has spun out of Université libre de Bruxelles with $19.6m in funding to commercialise treatments for cancer based on a new understanding on tumour metastasis.

The newly-launched UCLA spinout is targeting rare and treatment-resistant forms of epilepsy with an approach drawing on certain kinds of gut bacteria.

Beetlebox has been launched by Imperial Innovations to commercialise research conducted by Andrew Swirski.

Epic Conjoint, This is Seaweed and Travacoin have spun into NovaUCD, the innovation hub at University College Dublin, with a view of raising $8.7m within two years.